INTRODUCTION
Lipopolysaccharide (LPS), a major constituent in the outer membrane of gram-negative bacteria, is the major stimuli of microglial production of tumor necrosis factor (TNF)-a that causes brain inflammation [1] . Interleukin-10 (IL-10) inhibits LPS-induced TNF-a expression in an autocrine manner, suggesting that IL-10 produced by microglia counteracts over-expression of TNF-a in the brain [2] . IL-10, therefore, appears to be an important anti-inflammatory modulator of glial activation in order to maintain balance between proand anti-inflammatory cytokines in the CNS [2, 3] .
The induction of TNF-a in LPS-activated microglia has been well characterized to be mediated by signal pathways including protein kinase C (PKC), protein tyrosine kinase, and mitogen-activated protein kinase (MAPK), as well as transcription factors such as nuclear factor-kB (NF-kB) and activator protein-1 (AP-1) [4, 5] . The receptor responsible for transmitting the LPS signal across the plasma membrane has been recently identified as the Toll-like receptor 4 (TLR4) [6] . On the other hand, a recent study suggests that functionally important binding sites for NF-kB or AP-1 are absent in the IL-10 promoter [7] . Instead, IL-10 promoter activity in macrophages is strongly dependent on a binding site for Sp1 transcription factor that regulates IL-10 gene transcription via p38 MAPK [8] . However it is unclear whether the signal pathways activated by TLR4 signaling are directly involved in LPS-induced IL-10 expression in microglia.
Interestingly, recent studies suggest that activated immune cells release adenosine triphosphate (ATP) into the extracellular space in order to release cytokines by activating P2 purinergic receptor [9] . This view is also supported by a recent study, which showed ATP-evoked LPS-dependent release of IL-1b by activating P2X7 receptor in microglia [10] . Microglia express various receptors for ATP including metabotrophic P2Y receptors and ionotrophic P2X receptors such as P2X7 receptor, which respectively mobilize Ca 2 + from intracellular stores and trigger Ca 2 + influx across the plasma membrane [11] . Extracellular ATP is a potential mediator of inducible nitric oxide synthase (iNOS) expression [12] and TNF-a release in rat microglia via a P2X7 receptor [13] . In addition, ATP evokes the production of IL-6, a mediator of inflammation, in the microglial cell line MG-5 [14] , and induces maturation and release of IL-1b by activating the IL-1b-converting enzyme/caspase1 [15] . Therefore, we asked whether LPS-induced IL-10 production in microglia is regulated by P2 purinergic receptors activated by ATP that is secreted by microglia in an autocrine fashion in response to LPS stimulation.
MATERIALS AND METHODS
Microglial cell culture: Microglia cultures were prepared from the brains of 3-to 5-day-old Sprague-Dawley rats. Briefly, whole brain tissues were dissected into small cubes, incubated in Dulbecco's phosphate-buffered saline (JBI, Taegu, Korea) containing 0.1% trypsin and 40 mg/ml DNase I (Sigma, St. Louis, MO, USA) for 20 min at 371C, and dissociated into single cells by gentle pipetting. Dissociated cells were suspended in Dulbecco's modified Eagle's medium (DMEM; JBI) containing 5% horse serum (HS; JBI), 5 mg /ml glucose, 100 U/ml penicillin, 100 mg/ml streptomycin, plated in T-75 culture flasks, and incubated at 37 o C in an incubator with 5% CO 2 /95% air atmosphere. After 2-4 weeks of growth in flasks, microglia floating in the medium were collected and grown in separate 6-or 96-well plates.
RT-PCR analysis: To investigate the effects of apyrase on LPS-induced TNF-a and IL-10 gene expressions, microglial cells (1 Â 10 6 cells/well) were plated into 6-well plates in DMEM containing 0.1% HS, and treated with LPS (1 mg/ml) for 1, 3, 6, 12, or 24 h in the presence or absence of 2 units/ml apyrase. Total RNA was extracted using Trizol (Life Technologies, Rockville, MD, USA). Total RNA from each sample was subjected to DNase treatment and then processed for the first strand cDNA synthesis using Moloney murine leukemia virus (M-MLV) reverse transcriptase (Life Technologies). A 5 ml aliquot of each cDNA product was amplified by PCR using specific sense and antisense primers designed from the cDNA sequences for rat IL-10 and TNF-a. PCR primers for the IL-10 were Measurement of IL-10 and TNF-a release: To evaluate the effects of apyrase on LPS-induced TNF-a and IL-10 production, microglial cells (2 Â 10 4 cells/well) were plated into 96-well plates in DMEM containing 0.1% HS, and treated with LPS (1 mg/ml) in the presence or absence of apyrase (2 units/ml added every 12 h). The amount of IL-10 or TNF-a in the supernatant at various time points ranging from 3 h to 96 h was measured by enzyme-linked immunosorbent assay (ELISA). To assess which purinergic receptor was involved in LPS-stimulated induction of microglial IL-10 and TNF-a production, microglia cells were treated with ATP, ADP, adenosine 5'-O-(3-thiotriphosphate) (ATP-g-S), or adenosine 5'-O-(2-thiodiphosphate) (ADP-b-S; Sigma, St. Louis, MO, USA) at a concentration of 1-1000 nM for 24 h (for IL-10 assay) or 6 h (for TNF-a assay). For IL-10 and TNFa assay, we used Cytosets kit for rat IL-10 (Biosource, Camarillo, CA, USA) and Duoset ELISA development systems for rat TNF-a (R&D systems, Minneapolis, MN, USA) according to the manufacturer's protocol.
ATP efflux measurement:
To examine whether ATP is released by LPS treatment from microglia cells, microglia cells (2 Â 10 4 cells/well) were plated into 96-well plates in DMEM containing 0.1% HS, and treated in the absence or presence of 2 units/ml apyrase (Sigma, St. Louis, MO, USA) for 15 min prior to stimulation with 1 mg/ml LPS (Sigma) for various times. At the end of this incubation, the supernatant fluids of individual wells were transferred into sterile tubes and heated at 951C for 2 min. Extracellular ATP in the supernatants was immediately measured by the luminometer (TD2020, Turner Designs, Sunnyvale, CA, USA), using a luciferase-luciferin assay (ATP bioluminescent assay kit from Sigma) following the instructions of the manufacturer.
Statistical analysis: All statistical comparisons in this study were done using one-way ANOVA with TukeyKramer multiple comparisons test, and data were expressed as mean7s.e.m. po0.01 was considered significant.
RESULTS
In this study, we found that ATP released from LPSstimulated microglia triggered production of IL-10, but not TNF-a. As shown in Fig. 1a , stimulation of LPS led to a timedependent release of IL-10 and TNF-a. IL-10 release from LPS-treated cells was continuously increased by 96 h, but TNF-a secretion was reached to a maximum at 6 h and then continuously decreased by 96 h. When microglia were treated with LPS in the presence of ATP-hydrolyzing enzyme, apyrase (2 units/ml), the amount of IL-10 release was suppressed to the basal level, but TNF-a secretion was unaffected, suggesting that the extracellular ATP released from LPS-stimulated microglia may trigger IL-10 expression but not TNF-a. On the contrary, the amount of LPS-induced TNF-a secretion was increased to 605.3713.5, 589.7716.4, and 548.2716.1 pg/ml by apyrase treatment, compared with the amount of TNF-a secretion (463.3732.4, 427.7736.7, and 383.7714.4 pg/ml) in the absence of apyrase 48, 72, 96 h after LPS treatment, respectively (po0.01, Fig. 1a ). The effects of apyrase treatment on the mRNA induction for IL-10 and TNF-a also resembled those of protein levels. As shown in Fig. 1b , the induction of IL-10 mRNA was significantly inhibited by apyrase treatment, but TNF-a mRNA expression remained unaffected.
Based on the time-courses of IL-10 and TNF-a expression and the effects of apyrase on LPS-evoked the production of IL-10 and TNF-a from microglia, we asked whether LPSstimulated microglia could release ATP into extracellular space. We assayed the ATP efflux from LPS-stimulated microglia pretreated with or without apyrase (2 units/ml) for various time points by luciferase-luciferin assay (Fig. 2a) . Extracellular ATP was increased rapidly to 11.370.9 nM after 5 min treatment with LPS (1 mg/ml). The amount of ATP released into the medium reached a maximum level (18.670.9 nM, po0.001) after 15 min stimulation with LPS, and then continuously decreased for 3 h, and sustained the plateau line (B10 nM) up to 12 h. In contrast, apyrase treatment completely abolished extracellular ATP released from LPS-evoked microglia (Fig. 2a) .
We then hypothesized that ATP secreted from microglia might have the role of inducing the production of IL-10, but not TNF-a in LPS-stimulated microglial cell. To evaluate this presumption, we tested whether extracellular ATP could induce the expression of IL-10 and TNF-a in microglia. Figure 2b ,c show that both extracellular ATP and ADP at a concentration of 1-1000 nM produced a significant increase in IL-10 in a dose-dependent manner, whereas TNF-a production remained unaltered. Microglia treated with 1, 10, 100, and 1000 nM ATP (or ADP) produced 320. (Fig. 2b,c) . These results suggest that ATP released from microglia and/or the hydrolysis product of ATP, ADP, is a potent stimulus for IL-10 expression in LPS-stimulated microglia.
To determine whether P2 purinergic receptors are involved in the LPS-triggered induction of IL-10 in microglia, we measured the release of IL-10 after treating microglia with P2 purinergic receptor agonists at a concentration of 0.1-1000 nM for 24 h. As shown in Fig. 3 , both ATP-g-S and ADP-b-S induced IL-10 release from microglia in a dose dependent manner. Microglia treated with 1, 10, 100, and 1000 nM ATP-g-S (or ADP-b-S) produced 485. (Fig. 3) , suggesting that ATP released from LPS-stimulated microglia and/or a hydrolysis product of ATP, ADP, may induce the IL-10 expression through the activation of P2Y receptors.
DISCUSSION
In this study, we show that LPS-induced IL-10 production in microglia is regulated by P2 purinergic receptors by demonstrating that ATP released from LPS-activated microglia potently induced IL-10 expression. This suggests that the direct cause of IL-10 induction in LPS-stimulated microglia may be a small dose of ATP (10-20 nM) released by microglia.
As shown in Fig. 1 , apyrase, an ATP-hydrolyzing enzyme, completely inhibited LPS-induced IL-10 expression at the level of both m-RNA and protein, but did not inhibit TNF-a expression. These findings imply that extracellular ATP may trigger IL-10 expression in LPS-activated microglia, while TNF-a expression does not depend on extracellular ATP.
These results also suggest that the regulation of LPSinduced IL-10 production in microglia is fundamentally different from the regulation of TNF-a production in microglia. It is worthwhile to note that the stimulation of P2 purinergic receptor is involved in IL-1b release stimulated by LPS in microglia [10] . Interestingly, TNF-a secretion by LPS-stimulated microglia after treatment with apyrase was increased compared to microglia treated with LPS alone, and this may indicate the role of ATP as a negative feedback modulator of TNF-a expression (Fig. 1a) . In accordance with these results, it was reported that IL-10 suppressed the LPS-induced production of TNF-a, IL-6 and NO in a dose-dependent manner [2, 3, 16] . Moreover, our previous study demonstrated that IL-10 reduces the TNF-a production by a negative feedback inhibition in an autocrine manner in thrombin-activated microglia [17] . Therefore, our results raised the possibility of IL-10 induction by ATP released from LPS-activated microglia, which may help us gain a better understanding of how microglia prevents overactivation.
We then tested the ability of microglial cells to release ATP in response to LPS stimulation. As shown in Fig. 2a , microglial cells stimulated with LPS released ATP, and this release was abolished by apyrase treatment. The amount of ATP released into the medium reached a maximum of B20 nM after 15 min stimulation with LPS, and then sustained the plateau of B10 nM up to 12 h. Consistent with this finding, a recent study showed that ATP efflux from either astrocytes or microglia occurred via ATP binding cassette (ABC) proteins, which play key role in controlling the ATP efflux [18] . In order to demonstrate that nanomolar range of ATP (10-20 nM) secreted from microglia can induce IL-10 expression in an autocrine manner, we showed that extracellular ATP and ADP at a concentration of 1-1000 nM induced IL-10 expression in a dose dependent (Fig. 2b,c) . A recent study showed that TNF-a expression in microglia was induced by millimolar range of ATP via P2X7 receptor [13] , and this raises a possibility that differential actions of ATP for activating expressions of IL-10 and TNF-a in microglia depend on the concentrations of extracellular ATP to activate different types of P2 purinergic receptors. Recently, the expressions of both P2Y receptors and P2X receptors including P2X7 on microglial cells were observed in acute slices of adult mouse brain [19] .
P2 purinergic receptors were responsible for the induction of IL-10 release from extracellular ATP-activated microglia. Non-hydrolyzable ATP analog ATP-g-S and ADP analog ADP-b-S induced IL-10 secretion from microglia in a dose dependent manner (1-1000 nM; Fig. 3 ). These data suggest that nanomolar range of ATP and/or a metabolite of ATP (ADP) may induce IL-10 release from LPS-activated microglia through the activation of P2Y receptors. P2Y1 or P2Y12 receptor could be postulated as candidates of the P2Y receptor subtypes for the nanomolar range of ATP and/or ADP-mediated IL-10 expression. Consistent with this idea, Simmon et al. [20] have recently reported that P2Y12 receptor of rat brain capillary endothelial cells exhibited high potencies with ATP and ADP analogues including 2-methylthio-ATP (2-MeSATP) and 2-methylthio-ADP (2-MeSADP). Moreover, recent studies have shown that extracellular ATP or ADP induce chemotaxis of cultured microglia through G i/o -coupled P2Y receptors [21] , and that selective expression of G i/o -coupled ATP receptor P2Y12 was also observed in rat microglia [22] . It was also reported that the expression of P2Y1 receptor was observed in microglia of the acute mouse brain slice [19] . Based on these previous studies and our results, we speculate that the IL-10 expression in this study may have occurred through the association of P2Y1 and P2Y12 receptors. Recently, the P2Y13 receptor, which shares a high sequence homology with the P2Y12 receptor and similar functional properties, has been identified in the brain [23] , suggesting the possibility that this receptor may also be involved in the low concentration ATP-mediated IL-10 expression in microglia. In fact, the doses of ATP used in this study were less than the effective concentrations for P2X receptors. However, we cannot rule out the P2X receptors action for the IL-10 release in this study since a previous study showed an ATP-mediated IL-1b release via P2X7 receptor activation in LPS-activated microglia in culture [10] , and Brough et al. [24] confirmed this result using cultured microglia prepared from P2X7 knock-out mice.
We conclude, therefore, that a low dose of ATP (10-20 nM) released by LPS is a potent stimulator of IL-10 release in microglia, and this may serve to maintain an appropriate balance between pro-and anti-inflammatory cytokines in the CNS. Our conclusion also suggests that microglia use is an efficient way to maintain the homeostasis of the brain parenchyma, using separate signaling pathways for IL-10 and TNF-a production. Future work on identifying the signaling pathways involved in the purinergic modulation of IL-10 expression in microglia will provide a better understanding of the mechanisms responsible for ATPmediated immune modulation in the CNS.
CONCLUSION
There is increasing evidence that the stimulation of purinergic receptors in autocrine and paracrine ways is involved in LPS-dependent microglial cell responses in the CNS. Our results showed that a low dose of ATP released by LPS is a potent stimulator of IL-10 release in microglia. Additionally, the activation of P2Y purinergic receptors was shown to be involved in LPS-induced IL-10 release. Moreover, given the trophic effects of IL-10 on suppressing the microglial activation, identification of different P2 purinergic signaling to microglia could be a rational basis for the understanding the role of extracellular ATP in maintaining an appropriate balance between pro-and anti-inflammatory cytokines in the CNS.
